Microprocessor controlled transdermal delivery of anticancer drugs 5-Fluorouracil (5-FU) and 6-Mercaptopurine (6-MP) was developed and in vitro evaluation was done. Drugs were loaded based on the pharmacokinetics parameters. In vitro diffusion studies were carried at different current density (0.0, 0.1, 0.22, 0.50 mA/cm
2). The patches were evaluated for the drug content, thickness, weight, folding endurance, flatness, thumb tack test and adhesive properties all were well with in the specification of transdermal patches with elegant and transparent in appearance. In vitro permeation studies through human cadaver skin showed, passive delivery (0.0 mA/cm
2) of 6-MP was low. As the current density was progressively increased, the flux also increased. the flux also increased with 0.1 mA/cm
2 for 15–20 min, but it was less than desired flux, 0.2 mA/cm
2 for 30 min showed better flux than 0.1 mA/cm
2 current, but lag time was more than 4 h, 0.5 mA/cm
2 current for more than 1 h, flux was >159 µg/cm
2 h which was desired flux for 6-MP. 5-FU flux reached the minimum effective concentration (MEC) of 54 μg/cm
2 h with 0.5 mA/cm
2 current for 30–45 min, drug concentration were within the therapeutic window in post-current phase. We concluded from Ohm’s Law that as the resistance decreases, current increases. Skin resistance decrease with increase in time and current, increase in the drug permeation. Interestingly, for all investigated current densities, as soon as the current was switched off, 5-FU and 6-MP flux decreased fairly, but the controlled drug delivery can be achieved by switching the current for required period of time.
相似文献